1. Home
  2. INUV vs CTSO Comparison

INUV vs CTSO Comparison

Compare INUV & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INUV
  • CTSO
  • Stock Information
  • Founded
  • INUV N/A
  • CTSO 1997
  • Country
  • INUV United States
  • CTSO United States
  • Employees
  • INUV N/A
  • CTSO N/A
  • Industry
  • INUV Advertising
  • CTSO Medical/Dental Instruments
  • Sector
  • INUV Consumer Discretionary
  • CTSO Health Care
  • Exchange
  • INUV Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • INUV 62.8M
  • CTSO 68.2M
  • IPO Year
  • INUV N/A
  • CTSO N/A
  • Fundamental
  • Price
  • INUV $0.40
  • CTSO $0.87
  • Analyst Decision
  • INUV Strong Buy
  • CTSO Buy
  • Analyst Count
  • INUV 2
  • CTSO 2
  • Target Price
  • INUV $2.00
  • CTSO $5.50
  • AVG Volume (30 Days)
  • INUV 1.2M
  • CTSO 149.4K
  • Earning Date
  • INUV 05-09-2025
  • CTSO 05-14-2025
  • Dividend Yield
  • INUV N/A
  • CTSO N/A
  • EPS Growth
  • INUV N/A
  • CTSO N/A
  • EPS
  • INUV N/A
  • CTSO N/A
  • Revenue
  • INUV $93,478,114.00
  • CTSO $35,332,238.00
  • Revenue This Year
  • INUV $28.36
  • CTSO $18.72
  • Revenue Next Year
  • INUV $12.18
  • CTSO $19.75
  • P/E Ratio
  • INUV N/A
  • CTSO N/A
  • Revenue Growth
  • INUV 18.20
  • CTSO 15.37
  • 52 Week Low
  • INUV $0.19
  • CTSO $0.70
  • 52 Week High
  • INUV $0.79
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • INUV 44.47
  • CTSO 42.92
  • Support Level
  • INUV $0.41
  • CTSO $0.81
  • Resistance Level
  • INUV $0.46
  • CTSO $0.90
  • Average True Range (ATR)
  • INUV 0.04
  • CTSO 0.06
  • MACD
  • INUV -0.01
  • CTSO 0.00
  • Stochastic Oscillator
  • INUV 2.82
  • CTSO 38.91

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: